QURE earnings: real EPS beat/miss history, analyst consensus Buy, P/E -11.50. Updated 2026-07-23.
uniQure (QURE) Research Hub
uniQure (QURE) trades on NASDAQ, NL in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 44.51 USD (-3.24%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -11.50, market cap 2.71B. This hub links to the full technical, earnings and options research available for QURE.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, NL |
| Last close | 44.51 USD (-3.24%) |
| 52-week range | 27.26 USD – 51.72 USD |
| Trend regime | Range |
| 14-day RSI | 44.6 (Bearish) |
| Trailing P/E | -11.50 |
| Market cap | 2.71B |
| Dividend yield | 0.00% |
Available research for QURE
Covered Call on QURE: how it works, illustrative setup around the real 44.51 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on QURE: how it works, illustrative setup around the real 44.51 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on QURE: how it works, illustrative setup around the real 44.51 USD price, max profit/loss, breakeven and when to use it. Educational.
QURE technical analysis: range, last 44.51 USD, RSI 44.6, 52w range 27.26 USD–51.72 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is QURE in?
uniQure (QURE) is classified under Healthcare (Biotechnology), listed on NASDAQ, NL.
Is QURE in an uptrend or downtrend?
As of 2026-09-11, QURE is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is QURE's trailing P/E ratio?
QURE's trailing P/E is -11.50, with a market cap of 2.71B. See the earnings research page for full valuation detail.